857410P

IG7

Avanti Research^™ - A Croda Brand, powder

• Synonym(e): N-((2S,3R)-3-hydroxy-1-oxo-1-(tridecylamino)butan-2-yl)-5-methoxy-1H-indole-2-carboxamide
• Empirische Formel (Hill-System): C₂₇H₄₃N₃O₄
• CAS-Nummer: 2132345-13-0
• Molekulargewicht: 473.65
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Assay: 99% (TLC)
• Form: powder
• Verpackung: pkg of 1 × 1 mg (857410P-5mg); pkg of 1 × 5 mg (857410P-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand
• Lipid-Typ: bioactive lipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: C[C@@H](O)[C@H](NC(C(N1)=CC2=C1C=CC(OC)=C2)=O)C(NCCCCCCCCCCCCC)=O
• InChIKey: RAXJRRQLMVPSON-NLFFAJNJSA-N

Beschreibung

Allgemeine Beschreibung

IG7 is a ceramide analog.

Biochem./physiol. Wirkung

IG7 is potent in enhancing Fas ligand (FasL) induced apoptosis in colon carcinoma cells SW480 and RKO. IG7 enhances FasL mediated phosphorylation of p38 and janus kinase (JNK). IG7 enhances nuclear factor-kappa B (NF-κB) activation by FasL. IG7 exhibits low toxicity.

Verpackung

5ML Glass Amber Screw Cap Vial (857410P-1MG)

5ML Glass Amber Screw Cap Vial (857410P-5MG)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable